Pharmacological studies of pulmonary anaphylaxis in vitro: a review.
Ogunbiyi
P O
PO
Eyre
P
P
D000707:Anaphylaxis / Q000276:immunology* / Q000378:metabolism / Q000503:physiopathology; D000818:Animals; D000941:Antigens / Q000276:immunology; D002469:Cell Separation; D002631:Chemotactic Factors, Eosinophil / Q000378:metabolism; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D006636:Histamine Release; D006801:Humans; D066298:In Vitro Techniques; D007705:Kinins / Q000378:metabolism; D008168:Lung / Q000098:blood supply / Q000276:immunology* / Q000378:metabolism; D008171:Lung Diseases / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D008407:Mast Cells / Q000276:immunology / Q000378:metabolism; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D010477:Perfusion; D010972:Platelet Activating Factor / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D013189:SRS-A / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013931:Thromboxanes / Q000378:metabolism; D014132:Trachea
D000941:Antigens; D002631:Chemotactic Factors, Eosinophil; D007705:Kinins; D010972:Platelet Activating Factor; D011453:Prostaglandins; D011943:Receptors, Adrenergic, beta; D013189:SRS-A; D013931:Thromboxanes; D012701:Serotonin; D004298:Dopamine